WORKERS COMPENSATION: Provides relative to the medical treatment schedule under workers' compensation (RE INCREASE SG EX See Note)
HB 819 revises Louisiana’s workers’ compensation medical treatment schedule. The bill would allow the schedule to be based on either the state-promulgated schedule or the Official Disability Guidelines (ODG) by MCG, and it states that care consistent with the schedule is tacitly approved and not subject to prior employer authorization. It also requires employers to pay invoices for treatment consistent with the schedule within 30 days, while preserving a process for employers to challenge that care if they can prove by clear and convincing evidence that it was not medically necessary.
The bill further narrows and replaces several existing statutory provisions governing how treatment outside the schedule is evaluated. It repeals multiple subsections of R.S. 23:1203.1, including provisions related to the medical advisory council’s prior framework, and substitutes new standards for treatment not covered by the ODG. Those standards emphasize evidence-based, interdisciplinary guidelines, current medical literature, and adoption by other states. The bill also includes a two-year review trigger: if the updated schedule does not reduce average medical costs after two years, the medical advisory council and the Office of Workers’ Compensation Administration would develop and promulgate the schedule under the revised framework.
In practical terms, the bill would change how workers’ compensation medical care is authorized, billed, and disputed in Louisiana. It would affect injured workers, medical providers, employers, insurers, the Office of Workers’ Compensation Administration, and the medical advisory council by shifting the operative treatment benchmark toward ODG and by accelerating payment of compliant invoices. It also changes the burden in disputes over covered care by requiring employers to meet a clear-and-convincing-evidence standard to deny treatment that fits the schedule.
The overall sentiment reflected in the bill materials is reform-oriented and cost-control focused, with the stated goal of reducing average medical costs while maintaining evidence-based treatment standards. Because there are no committee transcripts or recorded votes provided, there is no direct record here of debate or opposition. The structure of the bill suggests support for streamlining workers’ compensation medical decisions, but it also implies potential concern from providers or claimant advocates about tighter utilization controls and the repeal of existing review and council provisions.
HB 819 would amend R.S. 23:1203.1 to redefine the workers’ compensation medical treatment schedule, incorporate the Official Disability Guidelines (ODG) by MCG as an alternative governing standard, require prompt payment of compliant medical invoices, and raise the employer’s burden to challenge covered treatment. It would also repeal several subsections governing the current medical review and advisory structure, while preserving a two-year fallback mechanism if the revised schedule does not lower average medical costs. The bill would directly affect workers’ compensation claims administration, medical billing, treatment authorization, and dispute resolution in Louisiana.
The bill appears generally supportive of a more standardized, evidence-based, and cost-conscious workers’ compensation system. Its language emphasizes reducing medical costs, using current medical literature, and speeding payment for treatment that fits the schedule. No committee transcripts or vote records were provided, so there is no documented floor or committee opposition in the supplied materials, but the changes are the kind that often draw scrutiny from providers and injured-worker advocates because they can limit discretion in treatment approval and alter existing review procedures.
The main points of contention are likely to be the shift from the existing state-developed treatment schedule to the ODG framework, the repeal of multiple current-law provisions, and the higher evidentiary burden placed on employers to deny treatment that conforms to the schedule. Supporters would likely favor the bill’s emphasis on evidence-based care, faster payment, and cost containment, while opponents may argue that it reduces flexibility for individualized treatment decisions and weakens the role of the medical advisory council and existing review safeguards. The two-year cost-reduction trigger also suggests concern about whether the new approach will actually produce savings.